US Patent 10022384 17-hydroxyprogesterone ester-containing oral compositions and related methods
Patent 10022384 was granted and assigned to Lipocine Inc. on July, 2018 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10022384 17-hydroxyprogesterone ester-containing oral compositions and related methods
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.